We have also excluded patients with moderate or severe renal failure, because circulating levels of several biomarkers (copeptin, NT-proBNP, NGAL) are influenced by chronic kidney disease, independent from the coronary artery disease. The gene discussed is LCN2; the disease is kidney failure.